Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-12-002342
Filing Date
2012-08-20
Accepted
2012-08-20 06:02:38
Documents
1
Period of Report
2012-08-20

Document Format Files

Seq Description Document Type Size
1 6-K zk1211899.htm 6-K 24844
  Complete submission text file 0001178913-12-002342.txt   25821
Mailing Address 8 HARTOM ST., 3RD FLOOR, JERUSALEM L3 97775
Business Address 8 HARTOM ST., 3RD FLOOR, JERUSALEM L3 97775 972-2-5486555
BioCancell Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1211
Type: 6-K | Act: 34 | File No.: 333-179140 | Film No.: 121043861
SIC: 2834 Pharmaceutical Preparations